Enigma Health partners with Roche, ST Engineering to boost AI healthcare solutions

ST Engineering will integrate Enigma’s AI model into its Genie Studio platform.

Enigma Health, a spinoff from SingHealth Duke-NUS Academic Medical Centre, has signed two strategic memorandums of understanding (MOUs) with global healthcare giant Roche and ST Engineering’s Enterprise Digital division.

The partnership with Roche will use Enigma Health’s AI workflow to speed up clinical trial recruitment, improve market access, and enhance business intelligence.

Meanwhile, the deal with ST Engineering’s Enterprise Digital focuses on joint exploration of new business and market opportunities. Enigma Health’s small language model will be incorporated into ST Engineering’s AGIL® Genie Studio platform, enabling non-technical users to develop AI-powered healthcare applications more easily.

The partnership combines SingHealth’s clinical expertise with ST Engineering’s hospital command centre data management to improve healthcare operations, decision-making, and AI-driven clinical trials.

Enigma Health said it will also work with national HealthTech agency Synapxe to expand its platform across SingHealth and plans to grow its reach in Southeast Asia with pharma companies and healthcare providers.

The announcement was made by Minister of State Mdm Rahayu Mahzam at the “Scaling and Sustaining Healthcare with Gen AI” symposium at ATxSG 2025.